» Articles » PMID: 20681587

Effects of Lead and Mercury on the Blood Proteome of Children

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2010 Aug 5
PMID 20681587
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Heavy metal exposure in children has been associated with a variety of physiological and neurological problems. The goal of this study was to utilize proteomics to enhance the understanding of biochemical interactions responsible for the health problems related to lead and mercury exposure at concentrations well below CDC guidelines. Blood plasma and serum samples from 34 children were depleted of their most abundant proteins using antibody-based affinity columns and analyzed using two different methods, LC-MS/MS and 2-D electrophoresis coupled with MALDI-TOF/MS and tandem mass spectrometry. Apolipoprotein E demonstrated an inverse significant association with lead concentrations (average being one microgram/deciliter) as deduced from LC-MS/MS and 2-D electrophoresis and confirmed by Western blot analysis. This coincides with prior findings that Apolipoprotein E genotype moderates neurobehavioral effects in individuals exposed to lead. Fifteen other proteins were identified by LC-MS/MS as proteins of interest exhibiting expressional differences in the presence of environmental lead and mercury.

Citing Articles

Concentrations of the serum long-chain omega-3 polyunsaturated fatty acids and hair mercury in men in different apolipoprotein E phenotypes.

Fagerholm U, Virtanen H, Tuomainen T, Salonen J, Virtanen J Biometals. 2025; .

PMID: 40085364 DOI: 10.1007/s10534-025-00677-7.


Effects of Blood Lead Levels <10 µg/dL in School-Age Children and Adolescents: A Scoping Review.

Pennington A, Smith M, Chuke S, Cornwell C, Allwood P, Courtney J Pediatrics. 2024; 154(Suppl 2).

PMID: 39352036 PMC: 11610497. DOI: 10.1542/peds.2024-067808F.


Child and Adolescent Manganese Biomarkers and Adolescent Postural Balance in Marietta CARES Cohort Participants.

McBride D, Bhattacharya A, Sucharew H, Brunst K, Barnas M, Cox C Environ Health Perspect. 2024; 132(5):57010.

PMID: 38780454 PMC: 11114102. DOI: 10.1289/EHP13381.


A precision environmental health approach to prevention of human disease.

Baccarelli A, Dolinoy D, Walker C Nat Commun. 2023; 14(1):2449.

PMID: 37117186 PMC: 10147599. DOI: 10.1038/s41467-023-37626-2.


Neurological Impacts of Chronic Methylmercury Exposure in Munduruku Indigenous Adults: Somatosensory, Motor, and Cognitive Abnormalities.

Oliveira R, Pinto B, Reboucas B, Ciampi de Andrade D, Vasconcellos A, Basta P Int J Environ Res Public Health. 2021; 18(19).

PMID: 34639574 PMC: 8507861. DOI: 10.3390/ijerph181910270.


References
1.
Panza F, DIntrono A, Colacicco A, Capurso C, Pichichero G, Capurso S . Lipid metabolism in cognitive decline and dementia. Brain Res Rev. 2006; 51(2):275-92. DOI: 10.1016/j.brainresrev.2005.11.007. View

2.
Shor M, Boaz M, Gavish D, Wainshtein J, Matas Z, Shargorodsky M . Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus. Am J Cardiol. 2007; 100(12):1767-70. DOI: 10.1016/j.amjcard.2007.07.052. View

3.
Eravci M, Fuxius S, Broedel O, Weist S, Eravci S, Mansmann U . Improved comparative proteome analysis based on two-dimensional gel electrophoresis. Proteomics. 2007; 7(4):513-523. DOI: 10.1002/pmic.200600648. View

4.
Navas-Acien A, Guallar E, Silbergeld E, Rothenberg S . Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect. 2007; 115(3):472-82. PMC: 1849948. DOI: 10.1289/ehp.9785. View

5.
Virtanen J, Rissanen T, Voutilainen S, Tuomainen T . Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem. 2006; 18(2):75-85. DOI: 10.1016/j.jnutbio.2006.05.001. View